|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
AvidBiotics Sees New Angle for Personalized Medicine in Antibiotics
|
Luke Timmerman |
02/01/12 |
San Francisco
|
|
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic
|
Luke Timmerman |
01/31/12 |
San Diego
|
|
Astellas Scraps Antibiotic Partnership With Theravance
|
Luke Timmerman |
01/06/12 |
San Francisco
|
|
Trius Antibiotic Passes Pivotal Study Against Pfizer’s Zyvox
|
Luke Timmerman |
12/19/11 |
San Diego
|
|
Optimer Wins EU Approval for New Antibiotic
|
Luke Timmerman |
12/12/11 |
San Diego
|
|
Infinity, Idera, Civitas, & More Boston-Area Life Sciences Headlines
|
Erin Kutz |
12/02/11 |
Boston
|
|
Rib-X Pharma Files for IPO
|
Arlene Weintraub |
11/28/11 |
Boston
|
|
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
11/10/11 |
San Diego
|
|
Optimer Pulls in $10.6M in Sales, With Commercial Rollout of New Antibiotic
|
Luke Timmerman |
11/03/11 |
San Diego
|
|
Connect Lists Finalists for San Diego’s Most Innovative Product Awards
|
Bruce V. Bigelow |
09/28/11 |
San Diego
|
|
Aura Adds $4.5M, Syndax To Present Breast Cancer Results at ASCO, PKE Buys Caliper, & More Boston-Area Life Sciences News
|
Erin Kutz |
09/09/11 |
Boston
|
|
Trius Strikes Antibiotic Deal With Bayer, Pockets $25M
|
Luke Timmerman |
07/27/11 |
San Diego
|
|
Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News
|
Erin Kutz |
07/08/11 |
Boston
|
|
Rib-X Inks Research Agreement With Sanofi
|
Erin Kutz |
07/06/11 |
Boston
|
|
Optimer Wins FDA Approval of New Antibiotic for Hospital Infections
|
Luke Timmerman |
05/27/11 |
San Diego
|
|
Optimer Cruises Into Memorable Memorial Day Weekend, Awaiting FDA Word on Antibiotic
|
Luke Timmerman |
05/27/11 |
San Diego
|
|
Nestlé Acquires Prometheus, Trius Raises $30M in Private Placement, Canaan’s Bloch Discusses Advanced BioHealing Deal, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
05/26/11 |
San Diego
|
|
San Diego’s Trius Therapeutics Creates Options for the Next Generation of Antibiotics
|
Bruce V. Bigelow |
05/25/11 |
San Diego
|
|
Kleiner Perkins’ Bet on a Concrete Stomach, The Gates Foundation’s Out-of-the-Box Ideas, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/05/11 |
Seattle
|
|
Optimer Spokeswoman Killed
|
Bruce V. Bigelow |
05/04/11 |
San Diego
|
|
Kilimanjaro Energy Seeks to Pop Loose Trillions’ Worth of Underground Oil, Save the World
|
Luke Timmerman |
05/02/11 |
San Francisco
|
|
Indel Grabs $1.4M for Antibiotics
|
Luke Timmerman |
04/28/11 |
Seattle
|
|
Xenoport Wins FDA Green Light, The Coming ‘HealthTech’ Wave, More Genomes Go Public, & More Bay Area Life Sciences News
|
Luke Timmerman |
04/08/11 |
San Francisco
|
|
Optimer Antibiotic Gets Panel Nod, CareFusion Buys Vestara, Tracon Raises $16.5M, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
04/07/11 |
San Diego
|
|
Omeros Flunks Pivotal Trials, Dendreon’s Shareholder Hubbub, AVI Biopharma Nabs $30M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/07/11 |
Seattle
|
|
Optimer Inks Potential $47.5M-Plus Deal with Cubist to Help Sell Antibiotic
|
Ryan McBride |
04/06/11 |
San Diego
|
|
Optimer Wins FDA Panel Nod, Still Wrestling With Language to Describe Benefit
|
Luke Timmerman |
04/05/11 |
San Diego
|
|
Cubist Settles Key Litigation
|
Ryan McBride |
04/05/11 |
Boston
|
|
Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made
|
Luke Timmerman |
04/04/11 |
National
|
|
Optimer Nabs $68M in Stock Sale
|
Luke Timmerman |
02/11/11 |
San Diego
|
|
Page 1 of
4 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.